Publikationen

Grundlegende Voraussetzung für die flächendeckende Verbesserung der Behandlungskonzepte ist die Publikation der Forschungsergebnisse. iOMEDICO unterstützt die internationalen Richtlinien zu Transparenz und Veröffentlichung von medizinischen Forschungsergebnissen.

Wir präsentieren unsere Daten regelmäßig auf nationalen und internationalen Kongressen. Unsere Publikationen erscheinen in wissenschaftlich renommierten, internationalen Fachzeitschriften. Autoren sind die Studienleiter, Prüfärzte mit besonders hoher Patiententeilnahme und Wissenschaftler von iOMEDICO.

TITEL
STUDIE
JAHR
Anti-anemic treatment of cancer patients in German routine practice – data from a prospective cohort study, the Tumor Anemia Registry (TAR).

Steinmetz, T., Schröder, J., Plath, M., Link, H., Vogt, M., Frank, M., Marschner, N., 2015.

Supportive Care in Cancer 23(Suppl. 1), 361. doi:10.1007/s00520-015-2712-y

Abstract
Download

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: MASCC / Journal: Supportive Care in Cancer
TAR
2015
Chemotherapy-induced nausea and vomiting – treatment and patient-reported outcomes in German outpatient cancer centres: Final data from the Emesis-Registry.

Schröder, J., Wiegand, J., Dörfel, S., Jähnich, S., Boller, E., Marschner, N., 2015.

Support Care Cancer 23(Suppl. 1), S139. doi:10.1007/s00520-015-2712-y

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: MASCC / Journal: Supportive Care in Cancer
Emesis-Register
2015
Relevance of neo- or adjuvant pretreatment in patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab as first-line treatment – data from the prospective TKK registry.

Schnell, R., Trarbach, T., Broszeit-Luft, S., Musch, R., Wetzel, N., Kopfmann, S., Jänicke, M., Marschner, N., 2015.

Oncol Res Treat 38 (suppl 5)(V395), 114. doi:10.1159/000439070

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TKK
2015
Implementation of RAS testing in patients with metastatic colorectal cancer in German outpatient cancer centers – data from the clinical TKK registry.

Schnell, R., Trarbach, T., Broszeit-Luft, S., Musch, R., Frank, M., Kopfmann, S., Jänicke, M., Marschner, N., 2015.

Oncol Res Treat 38 (suppl 5)(V394), 113–114. doi:10.1159/000439070

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TKK
2015
Preliminary safety and efficacy results from the multicentre OTILIA observational study of bevacizumab-containing therapy in women with newly diagnosed ovarian cancer in Germany.

Mustea, A., Oskay-Oezcelik, G., Wimberger, P., Reichert, D., Forstbauer, H., Keller, M., Frank, M., Klawitter, S., Kiewitz, C., Mueller, M., Sehouli, J., 2015.

European Journal of Cancer 51 (suppl 3) 548. 10.1016/S0959-8049(16)31520-9

Abstract

Indikation: Other, Sonstige / Veranstaltung: ECCO (ESMO) / Journal: European Journal of Cancer
OTILIA
2015
No impact of increasing symptoms on quality of life? Longitudinal data from the German MALIFE-Project on patients receiving monochemo- and endocrine treatment for advanced breast cancer – results from the TMK registry group.

Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2015.

The Breast 24 (suppl3) (OR51), 39. doi:10.1016/S0960-9776(15)30063-1

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ABC3 / Journal: The Breast
TMK
2015
No impact of increasing symptom burden on quality of life? – Longitudinal data from the German MaLife-Project on patients receiving monochemo- and endocrine treatment for metastatic breast cancer.

Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2015.

Oncol Res Treat 38 (suppl 5)(V670), 202. doi:10.1159/00043907

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TMK
2015
Survival data from patients with advanced or metastatic renal cell carcinoma in routine practice differs significantly from clinical trial data – Analyses from the German clinical RCC Registry.

Marschner, N., Müller, L., Staehler, M., Nusch, A., Münz, M., Koska, M., Jänicke, M., Goebell, P., 2015.

Oncol Res Treat 38 (suppl.5)(V674), 204. doi:10.1159/000439070

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TNK
2015
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study.

Marschner, N., Arnold, D., Engel, E., Hutzschenreuter, U., Rauh, J., Freier, W., Hartmann, H., Frank, M., Jänicke, M., 2015.

Clinical Epidemiology 7, 295–303. doi:10.2147/CLEP.S73857

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: Journal of Clinical Epidemiology
TKK
2015
NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim – First Interim Analysis.

Kurbacher, C.M., Fietz, T., Diel, I.J., Egert, M., Hurtz, H.-J., Lück, A., Weide, R., Salat, C., Wolff, T., Zaiss, M., Klare, P., Losem, C., Illmer, T., Weißenborn, G., Steffens, C.-C., Schulze, M., Tesch, H., Oskay-Oezcelik, G., Teichmann, B., Harde, J., Scheuerlein, R.W., 2015.

Oncol Res Treat 38, 221–229. doi:10.1159/000381631

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: - / Journal: Oncology Research and Treatment
NADIR
2015